3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
4
Breast Neoplasms
3
Malignant Solid Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Spondylitis, Ankylosing
1
Smoking Cessation
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Mental Disorders
1
Melanoma
1
Malignant Female Reproductive System Neoplasm
1
Lupus Erythematosus, Systemic
1
Leukemia, Myeloid, Acute
1
Inflammatory Bowel Diseases
1
Head and Neck Neoplasms
1
Depressive Disorder
1
Crohn Disease
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Carcinoma, Non-Small-Cell Lung
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthritis, Reactive
1
Arthritis, Psoriatic
1
Advanced Malignant Solid Neoplasm
1
Interventions
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Cisplatin
7
Carboplatin
5
pembrolizumab
4
durvalumab
4
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
cemiplimab
3
Radiation
3
Pemetrexed
3
Paclitaxel
3
Cetuximab
3
Biopsy
3
(225)Ac-DOTA-c(RGDyK)
3
cabozantinib
2
atezolizumab
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Nivolumab
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
ALT-803
2
130-nm albumin-bound paclitaxel
2
zipalertinib
1
repotrectinib
1
poly ICLC
1
osimertinib
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma
×
Interviews as Topic
×
30 days
×
Clear all
No trials found.